Skip to main content


Consortium for Canine Comparative Oncology


The Consortium for Canine Comparative Oncology (C3O) is a collaboration between the Duke Cancer Institute and North Carolina State University College of Veterinary Medicine. Duke and NC State have joined forces to further explore new cancer therapies offering better efficacy and less toxicity for both humans and canines. Researchers at both institutions are studying naturally occurring cancers in humans and canines and this collaboration will allow investigators to leverage research and resources to benefit both species, ensuring better treatments and outcomes.

"It is a great opportunity to create a partnership that simultaneously benefits humans and pets with cancer and facilitates research into the development of new diagnostics and therapies for both."

Michael B. Kastan, MD, PhD
Executive Director
Duke Cancer Institute

"There are phenomenal opportunities for this unique partnership, with huge promises for animals and people."

D. Paul Lunn, BVSc, MS, PhD, MRCVS, Dip. ACVIM
Dean of the College of Veterinary Medicine
North Carolina State University